Prostate cancer is a common form of cancer in men and is one of the leading cancer killers. Black men are disproportionately affected. They are often diagnosed at younger ages, with more advanced stages of cancer, with more aggressive cancers, and they may be more likely to need screening. Some of the differences in rates of survival between Black and White men may be due to differences in access to medical care.
Read More »Tag: Prostate
NCHR’s Testimony to FDA on TOOKAD to Treat Low-Risk Prostate Cancer
February 26, 2020. The long-term complications of TOOKAD to treat low-risk prostate cancer are unclear. We believe that better research needs to be completed before approval, especially because the sponsor did not comply with FDA’s recommendations for the study.
Read More »